RU95104235A - Агент для контроля плодовитости и содержащая его фармацевтическая композиция - Google Patents

Агент для контроля плодовитости и содержащая его фармацевтическая композиция

Info

Publication number
RU95104235A
RU95104235A RU95104235/14A RU95104235A RU95104235A RU 95104235 A RU95104235 A RU 95104235A RU 95104235/14 A RU95104235/14 A RU 95104235/14A RU 95104235 A RU95104235 A RU 95104235A RU 95104235 A RU95104235 A RU 95104235A
Authority
RU
Russia
Prior art keywords
group
rand
carbon atoms
hydrogen atom
hydroxyl
Prior art date
Application number
RU95104235/14A
Other languages
English (en)
Other versions
RU2176506C2 (ru
Inventor
Бонфис Армелль
Fr]
Филибер Даниель
Original Assignee
Руссель Юклаф (FR)
Руссель Юклаф
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Руссель Юклаф (FR), Руссель Юклаф filed Critical Руссель Юклаф (FR)
Publication of RU95104235A publication Critical patent/RU95104235A/ru
Application granted granted Critical
Publication of RU2176506C2 publication Critical patent/RU2176506C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives

Abstract

Предметом изобретения являются соединения формулы I, приведенной в описании, а также их соли с допустимыми с фармацевтической точки зрения кислотами для контроля плодовитости, в частности для контроля мужской плодовитости.

Claims (1)

  1. Предметом изобретения являются соединения формулы I, приведенной в описании, а также их соли с допустимыми с фармацевтической точки зрения кислотами для контроля плодовитости, в частности для контроля мужской плодовитости.
RU95104235/14A 1994-03-24 1995-03-23 Агент для контроля плодовитости и содержащая его фармацевтическая композиция RU2176506C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9403460A FR2717690B1 (fr) 1994-03-24 1994-03-24 Application de stéroïdes aromatiques 3 substitués par un aminoalcoxy substitué à l'obtention d'un médicament pour contrôler la stérilité, notamment masculine.
FR9403460 1994-03-24

Publications (2)

Publication Number Publication Date
RU95104235A true RU95104235A (ru) 1996-11-27
RU2176506C2 RU2176506C2 (ru) 2001-12-10

Family

ID=9461385

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95104235/14A RU2176506C2 (ru) 1994-03-24 1995-03-23 Агент для контроля плодовитости и содержащая его фармацевтическая композиция

Country Status (16)

Country Link
US (5) US5554604A (ru)
EP (1) EP0676202B1 (ru)
JP (1) JP3678454B2 (ru)
KR (1) KR100367805B1 (ru)
CN (1) CN1055391C (ru)
AT (1) ATE193650T1 (ru)
AU (1) AU698349B2 (ru)
CA (1) CA2145469A1 (ru)
DE (1) DE69517356T2 (ru)
DK (1) DK0676202T3 (ru)
ES (1) ES2147267T3 (ru)
FR (1) FR2717690B1 (ru)
GR (1) GR3033882T3 (ru)
HU (1) HUT72085A (ru)
PT (1) PT676202E (ru)
RU (1) RU2176506C2 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742337B1 (fr) * 1995-12-13 1998-03-06 Roussel Uclaf Application du 3-alpha-hydroxy-5-alpha-androsta-16-ene a titre de medicaments
US5834225A (en) * 1997-01-15 1998-11-10 Board Of Trustees Operating Michigan State University Method, device and test kit for capacitation of sperm
DE19917930A1 (de) * 1999-04-15 2000-10-19 Schering Ag Ent-Steroide als selektiv wirksame Estrogene
US6844456B2 (en) * 2000-11-03 2005-01-18 Washington University Modified, hydroxy-substituted aromatic structures having cytoprotective activity
US20020132802A1 (en) * 2000-11-17 2002-09-19 Washington Univeristy Cytoprotective polycyclic compounds
JP4045090B2 (ja) * 2001-11-06 2008-02-13 オムロン株式会社 静電アクチュエータの調整方法
US7687486B2 (en) * 2003-04-29 2010-03-30 Florida Agricultural & Mechanical University Selective estrogen receptor modulators
US10397672B2 (en) 2016-06-20 2019-08-27 Cable Television Laboratories, Inc. Systems and methods for intelligent edge to edge optical system and wavelength provisioning

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL120166C (ru) * 1961-08-11
FR1338308A (fr) * 1961-08-11 1963-09-27 Roussel Uclaf Stéroïdes aromatiques substitués en position 3 et procédé de préparation
GB984028A (en) * 1963-01-17 1965-02-24 Parke Davis & Co Estradiol derivatives and methods for their production
GB984029A (en) * 1963-01-17 1965-02-24 Parke Davis & Co Estrone derivatives and methods for their production
US3519714A (en) * 1966-03-15 1970-07-07 Herchel Smith Synthesis of gona-1,3,5(10)-trienes
FR2640977A2 (en) * 1982-06-11 1990-06-29 Roussel Uclaf New position-11 substituted 19-norsteroids and their application as medicinal products.
SE8802402D0 (sv) * 1988-06-28 1988-06-28 Pharmacia Ab Novel esters
GB9226489D0 (en) * 1992-12-19 1993-02-10 Univ Manchester A joint
KR100984028B1 (ko) * 2008-01-06 2010-10-01 전현철 새콤달콤한 조성물을 난(卵)에 전이하여 구운 새로운 향미의 도포 난(卵) 제조방법
KR102037155B1 (ko) * 2018-11-28 2019-10-28 김훈 다중 레이어를 갖는 프라모델 완성품 보관 및 전시케이스

Also Published As

Publication number Publication date
DE69517356D1 (de) 2000-07-13
AU1495695A (en) 1995-10-05
KR950031078A (ko) 1995-12-18
CA2145469A1 (fr) 1995-09-25
FR2717690A1 (fr) 1995-09-29
HUT72085A (en) 1996-03-28
AU698349B2 (en) 1998-10-29
ES2147267T3 (es) 2000-09-01
JPH07285988A (ja) 1995-10-31
CN1055391C (zh) 2000-08-16
US5739124A (en) 1998-04-14
JP3678454B2 (ja) 2005-08-03
HU9500846D0 (en) 1995-05-29
EP0676202A3 (fr) 1995-12-27
FR2717690B1 (fr) 1996-04-26
PT676202E (pt) 2000-09-29
US5635498A (en) 1997-06-03
EP0676202B1 (fr) 2000-06-07
EP0676202A2 (fr) 1995-10-11
US5580864A (en) 1996-12-03
US5554604A (en) 1996-09-10
DE69517356T2 (de) 2000-12-14
GR3033882T3 (en) 2000-11-30
CN1111988A (zh) 1995-11-22
ATE193650T1 (de) 2000-06-15
US5672595A (en) 1997-09-30
RU2176506C2 (ru) 2001-12-10
DK0676202T3 (da) 2000-10-16
KR100367805B1 (ko) 2003-08-02

Similar Documents

Publication Publication Date Title
KR830006174A (ko) 기관지 항경련성 화합물 제조방법
US4476308B1 (ru)
RU94037246A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования разрушения хряща
RU95104235A (ru) Агент для контроля плодовитости и содержащая его фармацевтическая композиция
DK607783D0 (da) Nitroaliphatiske forbindelser
DK163144C (da) Diethylaminoalkoxybenzhydrolderivater og farmaceutisk acceptable syreadditionssalte og kvaternaere ammoniumsalte deraf, fremgangsmaade til fremstilling heraf, farmaceutisk praeparat og fremgangsmaade til fremstilling heraf
DK601683D0 (da) Dialkylaminoalkoxybenzylalkoholderivater
RU95110110A (ru) Производные бензофурана, способ их получения, фармкомпозиция и способ лечения
AU558203B2 (en) 1-hydroxy propyl resorcin derivatives
OA09324A (fr) "Procédé de préparation de (pyridyl-3)-2 tétrahydrothiopyrannecarbothioamide-2-oxydes-1-(1R,2R), les (pyridyl-3)-2 tétrahydrothiopyrannecarbothioamide-2-oxydes-1-(1R,2R) ainsi obtenus et les compositions pharmaceutiques qui les contiennent".
SE8303718L (sv) E-homo-enurnanderivat, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande dessa foreningar

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20070324